Call for Abstracts

Create your free IBDW account to submit → Already have an account? Sign in and use Submit an abstract on your account page.

Key dates

• Submissions open: October 28, 2026
• Submission deadline: January 6, 2027
• Decisions sent: February 17, 2027
• Presenters must register by: March 2, 2027

What we're looking for

We invite abstracts on original research in breast density and breast cancer risk assessment: measurement, biology, imaging and AI, integrated risk prediction, screening and prevention, and equity and implementation. Every accepted abstract is presented twice: as a 90-second Lightning Talk in the main session and as a Lounge Poster. The Scientific Advisory Committee invites some abstracts to give a longer proffered talk. Trainees and first-time presenters are welcome.

When you submit, you choose the one category that fits your work best:

Breast density: measurement, biology, and change over time

Density measures, density change over time, hormones, obesity, environment, tissue composition

Image-derived risk and imaging biomarkers

AI risk from mammography, tomosynthesis, MRI background parenchymal enhancement, contrast-enhanced imaging, short-term versus long-term risk

Integrated risk prediction

Polygenic scores, omics, clinical factors and imaging combined; validation, calibration, and transportability to new populations

From risk to action

Risk-based screening, supplemental imaging, prevention, density notification, clinical pathways, cost-effectiveness

Equity, communities, and implementation

Hispanic, Indigenous, and other racial and ethnic minority populations, including Native Hawaiian and Pacific Islander communities; underserved populations; risk communication, shared decision making, and implementation in practice

Data science methods and infrastructure

Work whose main contribution is the method: evaluation frameworks, bias and fairness audits, model drift, federated and multi-site learning, foundation models, large language models, synthetic data, open datasets and benchmarks

Emerging and other

New directions that fit none of the above. Describe the area in one line; the Scientific Advisory Committee may reassign it during review

You also choose up to 3 method and data tags:

• Biological basis and mechanisms of action
• Deep learning or computer vision
• Foundation models or large language models
• Classical statistics or epidemiology
• Causal inference
• Longitudinal data (repeated exams, trajectories)
• Multimodal integration (imaging with genetic, omic, or clinical data)
• Multi-site or privacy-preserving analysis
• External validation, fairness, or bias assessment
• Simulation or health economics
• Qualitative or community-engaged methods
• New dataset, benchmark, or open code released

Work that spans several categories is welcome. Choose the closest one and say so in the abstract.

Format

• Title: up to 200 characters.
• Abstract: up to 300 words in four parts: Background, Methods, Results, Conclusions. Results should be present, not promised.
• Optional: one figure or table with a caption, up to three references, and a funding line. These do not count toward the 300 words.

Before you submit

• Create a free IBDW account first. You submit from your account page, so your abstract is linked to you.
• You don't need to pay before you submit. Decisions go out February 17, two weeks before early registration closes on March 2, so accepted presenters can pay at the early rate.
• Each person may present one abstract and co-author any number.
• The presenting author must register by March 2, 2027, or the abstract is withdrawn from the program.
• Accepted abstracts are published open access in a supplement of Breast Cancer Research. By submitting, all authors agree to publication of the abstract there.
• If the abstract describes an individual patient or includes potentially identifiable details (age, gender, location, condition, treatment), you need the patient's informed consent to publish, and the abstract must say so.
• Abstracts presented at other meetings or posted as preprints are welcome. Abstracts whose full article is already published in a journal cannot be included.

What the form asks for

Worth gathering before you start:

• Presenting author: name, email, affiliation (ORCID optional)
• Co-authors and their affiliations
• Title and abstract body
• Optionally, one figure or table (PNG, JPG or PDF, up to 5 MB) with a caption of up to 50 words, up to three references, and a funding line
• Primary category (one) and up to three method and data tags
• Conflict-of-interest disclosures
• Whether the work has been published previously

How accepted abstracts are presented

How review works

Each abstract is scored by two members of the Scientific Advisory Committee from January 12 to 26, 2027. The committee meets in early February to decide acceptance and to invite some abstracts to give proffered talks. Reviewers abstain on any abstract where they have a conflict.

Abstracts are judged on:

• Scientific quality and rigor
• Relevance to breast density and cancer risk assessment
• Originality of the work
• Clarity of the abstract

Decisions go out by email on February 17, 2027, and you can check the status of your own abstract any time on your account page.

Questions

Email abstracts@breastdensityworkshop.org.

Create your free IBDW account to submit →